Dossier
Christopher L. Jacobs
Rep. Christopher L. Jacobs (R-NY) · disclosures Feb 17 – Jan 20
The Potomac LedgerWashington Intelligence
Christopher L. Jacobs
Rep. Christopher L. Jacobs (R-NY)
Most-traded: $SAVA · Top sector: Energy$2.5M – $8.6M disclosed
263Disclosures
—no current committee
59Late filings
-3.7%Avg mkt-adj 3mo
potomacledger.com · Nonpartisan · Not investment advice
263Disclosures
—No current committee — not screened
22%Late rate (59)
-3.7%Avg mkt-adj 3 months
$2.5M – $8.6MDisclosed $ volume
Disclosed trades
| Disclosed | Traded | Action | Ticker / Asset | Amount | Sector | Flags |
|---|---|---|---|---|---|---|
| Jan 20 | Dec 12 | P | $AROC Archrock (AROC) | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | P | $ATHA Athira Pharma (ATHA) | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | S | $BAC Bank of America (BAC) | $1K–$15K | Financial Services | |
| Jan 20 | Dec 12 | P | $BRK.B Berkshire Hathaway New | $1K–$15K | — | |
| Jan 20 | Dec 12 | S | $BLFS BioLife Solutions (BLFS) | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | P | $BORR Borr Drilling Limited | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | P | $MNRL Brigham Minerals | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | P | $SAVA Cassava Sciences | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | S | $CVX Chevron | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | P | $CHRD Chord Energy | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $CIVI Civitas Resources | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | P | $CMTG Claros Mortgage Trust (CMTG) | $1K–$15K | Real Estate | |
| Jan 20 | Dec 12 | P | $COGT Cogent Biosciences (COGT) | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | S | $CTRA Coterra Energy | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $CRGY Crescent Energy Company | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $XPRO Expro N.V. | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $XOM Exxon Mobil (XOM) | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | P | $FHN First Horizon (FHN) | $1K–$15K | Financial Services | |
| Jan 20 | Dec 12 | P | $GEVO Gevo | $1K–$15K | Basic Materials | |
| Jan 20 | Dec 12 | S | $HLX Helix Energy Solutions (HLX) | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $HP Helmerich & Payne (HP) | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $HD Home Depot | $1K–$15K | Consumer Cyclical | |
| Jan 20 | Dec 12 | S | $NOTV Inotiv | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | P | $INSW.V International Seaways | $1K–$15K | — | |
| Jan 20 | Dec 12 | S | $JPM JP Morgan Chase & (JPM) | $1K–$15K | Financial Services | |
| Jan 20 | Dec 12 | P | $KALV KalVista Pharmaceuticals (KALV) | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | P | $KRYS Krystal Biotech (KRYS) | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | P | $KURA Kura Oncology (KURA) | $1K–$15K | Healthcare | |
| Jan 20 | Dec 6 | P | Louisiana ST 5.000% 3/01/31 | $15K–$50K | — | |
| Jan 20 | Dec 12 | S | $META Meta Platforms | $1K–$15K | Communication Services | |
| Jan 20 | Dec 12 | P | $NESR National Energy Services Reunited | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | P | $NTST NetSTREIT (NTST) | $1K–$15K | Real Estate | |
| Jan 20 | Dec 12 | P | $PR Permian Resources | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $PFE Pfizer | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | P | $DOC Physicians Realty Trust | $1K–$15K | Real Estate | |
| Jan 20 | Dec 12 | P | $PXD Pioneer Natural Resources Company (PXD) | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $RLMD Relmada Therapeutics (RLMD) | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | P | $SWTX SpringWorks Therapeutics | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | P | $TELL Tellurian | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $TSLA Tesla | $1K–$15K | Consumer Cyclical | |
| Jan 20 | Dec 12 | S | $UEC Uranium Energy (UEC) | $1K–$15K | Energy | |
| Jan 20 | Dec 12 | S | $PCVX Vaxcyte | $1K–$15K | Healthcare | |
| Jan 20 | Dec 12 | S | $AVXL Anavex Life Sciences | $1K–$15K | Healthcare | |
| Dec 12 | Nov 8 | P | $UEC Uranium Energy (UEC) | $1K–$15K | Energy | |
| Dec 12 | Nov 8 | P | $AGNC AGNC Investment | $1K–$15K | Real Estate | |
| Dec 12 | Nov 8 | P | $AKRO Akero Therapeutics (AKRO) | $1K–$15K | Healthcare | |
| Dec 12 | Nov 8 | S | $ATHA Athira Pharma (ATHA) | $1K–$15K | Healthcare | |
| Dec 12 | Nov 8 | S | $BCEL Atreca | $1K–$15K | Healthcare | |
| Dec 12 | Nov 8 | P | $BAC Bank of America (BAC) | $1K–$15K | Financial Services | |
| Dec 12 | Nov 8 | P | $BRK.A Berkshire Hathaway | $1K–$15K | — |
Showing 50 of 263 disclosures — full history in The Full Ledger (see the data dictionary).
Disclosures are drawn entirely from public STOCK Act and OGE Form 278-T filings; a conflict flag marks a trade in a sector the member's committee oversees (a signal to read, not a finding of wrongdoing). The average market-adjusted return is a descriptive summary of how these already-disclosed trades fared versus the market — it is not a prediction and not investment advice. Conflict screening compares trades only to the sectors a member's current committees oversee; members with no current committee seat (departed members, chamber leadership) aren't screened, so a 0 (or —) here is not an all-clear. See our methodology and data dictionary.
See how every flag is defined — and verify it against the original filings.
Read the methodology All tracked officials